Swiss Life Asset Management’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $66.4M | Buy |
525,655
+136,175
| +35% | +$17.9M | 0.28% | 72 |
|
|
2026
Q1 | $54.3M | Buy |
389,480
+18,110
| +5% | +$2.54M | 0.27% | 72 |
|
|
2025
Q4 | $45.6M | Sell |
371,370
-197,901
| -35% | -$24.1M | 0.23% | 84 |
|
|
2025
Q3 | $63.2M | Buy |
569,271
+31,807
| +6% | +$3.62M | 0.33% | 61 |
|
|
2025
Q2 | $59.6M | Sell |
537,464
-21,415
| -4% | -$2.28M | 0.35% | 62 |
|
|
2025
Q1 | $62.6M | Buy |
558,879
+19,353
| +4% | +$2M | 0.46% | 45 |
|
|
2024
Q4 | $49.8M | Buy |
539,526
+36,973
| +7% | +$3.33M | 0.37% | 56 |
|
|
2024
Q3 | $42.1M | Buy |
502,553
+68,068
| +16% | +$5.19M | 0.48% | 41 |
|
|
2024
Q2 | $29.8M | Sell |
434,485
-22,096
| -5% | -$1.47M | 0.35% | 60 |
|
|
2024
Q1 | $33.4M | Buy |
456,581
+1,403
| +0.3% | +$108K | 0.46% | 47 |
|
|
2023
Q4 | $36.9M | Sell |
455,178
-65,096
| -13% | -$5.07M | 0.44% | 37 |
|
|
2023
Q3 | $39M | Buy |
520,274
+19,858
| +4% | +$1.53M | 0.6% | 27 |
|
|
2023
Q2 | $38.6M | Sell |
500,416
-14,981
| -3% | -$1.19M | 0.57% | 28 |
|
|
2023
Q1 | $42.8M | Buy |
515,397
+136,143
| +36% | +$11.3M | 0.64% | 25 |
|
|
2022
Q4 | $32.6M | Sell |
379,254
-40,490
| -10% | -$3.21M | 0.54% | 33 |
|
|
2022
Q3 | $25.9M | Sell |
419,744
-43,494
| -9% | -$2.74M | 0.45% | 38 |
|
|
2022
Q2 | $28.7M | Buy |
463,238
+47,284
| +11% | +$2.93M | 0.46% | 37 |
|
|
2022
Q1 | $24.7M | Buy |
415,954
+10,751
| +3% | +$687K | 0.35% | 58 |
|
|
2021
Q4 | $29.4M | Buy |
405,203
+152,889
| +61% | +$10.5M | 0.38% | 54 |
|
|
2021
Q3 | $17.6M | Sell |
252,314
-45,056
| -15% | -$3.17M | 0.24% | 94 |
|
|
2021
Q2 | $15.6M | Sell |
297,370
-4,558
| -2% | -$304K | 0.16% | 118 |
|
|
2021
Q1 | $19.5M | Buy |
301,928
+7,105
| +2% | +$458K | 0.28% | 80 |
|
|
2020
Q4 | $17.2M | Buy |
294,823
+234,377
| +388% | +$14.1M | 0.25% | 89 |
|
|
2020
Q3 | $3.82M | Sell |
60,446
-92,078
| -60% | -$6.39M | 0.06% | 227 |
|
|
2020
Q2 | $11.7M | Buy |
152,524
+63,198
| +71% | +$4.84M | 0.19% | 108 |
|
|
2020
Q1 | $6.68M | Buy |
89,326
+41,561
| +87% | +$2.87M | 0.13% | 138 |
|
|
2019
Q4 | $3.1M | Sell |
47,765
-73,662
| -61% | -$4.8M | 0.06% | 257 |
|
|
2019
Q3 | $7.7M | Sell |
121,427
-21,141
| -15% | -$1.38M | 0.1% | 149 |
|
|
2019
Q2 | $9.62M | Buy |
142,568
+54,238
| +61% | +$3.57M | 0.12% | 131 |
|
|
2019
Q1 | $5.74M | Sell |
88,330
-468,140
| -84% | -$31.1M | 0.07% | 169 |
|
|
2018
Q4 | $34.8M | Sell |
556,470
-292,057
| -34% | -$20.4M | 0.71% | 35 |
|
|
2018
Q3 | $65.5M | Buy |
848,527
+440,262
| +108% | +$33.3M | 0.88% | 23 |
|
|
2018
Q2 | $28.9M | Sell |
408,265
-299,355
| -42% | -$21.1M | 0.43% | 62 |
|
|
2018
Q1 | $53.3M | Buy |
707,620
+414,259
| +141% | +$32.9M | 0.93% | 18 |
|
|
2017
Q4 | $21M | Buy |
293,361
+68,784
| +31% | +$5.22M | 0.47% | 74 |
|
|
2017
Q3 | $18.2M | Buy |
224,577
+5,675
| +3% | +$434K | 0.49% | 65 |
|
|
2017
Q2 | $15.5M | Buy |
218,902
+7,391
| +3% | +$492K | 0.4% | 70 |
|
|
2017
Q1 | $14.4M | Buy |
211,511
+128,295
| +154% | +$9.02M | 0.39% | 74 |
|
|
2016
Q4 | $5.96M | Sell |
83,216
-99,656
| -54% | -$7.41M | 0.2% | 97 |
|
|
2016
Q3 | $14.5M | Buy |
182,872
+487
| +0.3% | +$39.6K | 0.49% | 55 |
|
|
2016
Q2 | $15.2M | Buy |
182,385
+31,362
| +21% | +$2.78M | 0.62% | 44 |
|
|
2016
Q1 | $13.9M | Buy |
151,023
+9,691
| +7% | +$874K | 0.59% | 43 |
|
|
2015
Q4 | $14.3M | Buy |
141,332
+7,519
| +6% | +$782K | 0.64% | 41 |
|
|
2015
Q3 | $13.1M | Buy |
133,813
+9,353
| +8% | +$1.04M | 0.64% | 37 |
|
|
2015
Q2 | $14.6M | Sell |
124,460
-2,944
| -2% | -$322K | 0.51% | 29 |
|
|
2015
Q1 | $12.5M | Buy |
+127,404
| New | +$12.9M | 0.5% | 40 |
|
Other funds holding GILD
N
Swiss Life Asset Management's GILD Position: Q2 2026 in Review
Swiss Life Asset Management increased its Gilead Sciences (GILD) stake by 35% in Q2 2026, buying an estimated $17.9M and bringing the position to 525,655 shares worth $66.4M. The position accounts for 0.28% of the portfolio, ranked #72.
Swiss Life Asset Management first reported a position in GILD in Q1 2015 and has held it in 46 quarters since. 1,671 funds tracked by Wall St. Rank hold GILD as of Q2 2026.
- Swiss Life Asset Management held 525,655 shares of Gilead Sciences worth $66.4M as of Q2 2026.
- Swiss Life Asset Management bought 136,175 Gilead Sciences shares in Q2 2026, an estimated $17.9M.
- Gilead Sciences made up 0.28% of Swiss Life Asset Management's portfolio in Q2 2026, its #72 holding.
- Swiss Life Asset Management first reported a position in Gilead Sciences in Q1 2015 and has held it in 46 quarters since.
- 1,671 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.
Based on Swiss Life Asset Management's 13F filing for Q2 2026, filed 29 Jul 2026.